The Current Capacity and Future Development of Economic Evaluation for Policy Decision-Making: A Survey among Researchers and Decision-Makers in Thailand. Usa Chaikledkaew1,2 Chanida Lertpitakpong2 Yot Teerawattananon2 Montarat Thavorncharoensap1,2 Viroj Tangcharoensathien 3 1Department of Phar

20-208-2556collaboration project,Philippines,ความร่วมมือ

The Clinical Research Collaboration Network in collaboration with the HITAP conducted a clinical test of Randomized Controlled Trial (RCT) regarding the treatment of relapse or resistant proliferative lupus nephritis. The objective of this research was to determine the efficacy of enteric-coated Mycophenolate Sodium combined with corticosteroids fo

The decision-making challenge for reimbursing costly innovative drugs Health technology assessment (HTA) is a multi-disciplinary approach crucial to the decision-making framework for drug reimbursements. It gives evidence of the drug’s cost-effectiveness and affordability to help policymakers decide

A special conference in the coming week on 13-15 May 2013 is another eye—catching event for the Health Technology Assessment (HTA) circles, especially in the Asia-Pacific region. The HTAsiaLink, a collaborative network between Asian Health Technology Assessment agencies, together with honorable gues

Following an assessment1 of the core strategies of HITAP carried out by a team of Thai and UK investigators in 2007-2008, at the request of the Thai Health Promotion Foundation, HITAP has initiated a second evaluation, in 2011, this time bringing together a team of UK, Thai and Korean assessors. These recommendations were the result of data analysi

Thanchanit Thaipitakwong is currently a Senior Content Creator at HITAP, responsible for planning and delivering research communication to the public and developing content in various formats tailored to different audiences and platforms. With a background in pharmacy and experience in medical communication, she focuses on making complex academic c

(Reuters) – Victims of thalidomide said on Saturday an apology from the German inventor of the drug that caused birth defects in thousands of babies around the world was too little too late.Thalidomide, developed by the German firm Gruenenthal, was marketed internationally to pregnant women in the l

Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health through the International Decision Support Initiative (iDSI) has been working in Vietnam since 2014. iDSI has supported Ministry of Health (MOH) Vietnam in realising Universal Health Coverage (UHC) through a dif